Advertisement

Topics

Cost-effectiveness of allergen immunotherapy evaluated

13:30 EDT 31 Jul 2017 | Medical Xpress

(HealthDay)—Allergen immunotherapy (AIT) may be cost-effective for allergic rhinitis, and for venom allergy in high-risk subgroups, according to research published online July 18 in Allergy.

Original Article: Cost-effectiveness of allergen immunotherapy evaluated

NEXT ARTICLE

More From BioPortfolio on "Cost-effectiveness of allergen immunotherapy evaluated"

Quick Search
Advertisement
 

Relevant Topic

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...